Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Cancer cell or component thereof
Reexamination Certificate
2001-05-15
2010-02-09
Rawlings, Stephen L (Department: 1643)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Cancer cell or component thereof
C530S300000, C530S350000
Reexamination Certificate
active
07658935
ABSTRACT:
Methods for stimulating the immune system of an individual to produce and release antimalignin antibody are disclosed. The method comprises administering an amount of a composition containing malignin, recognin M, recognin L, or a peptide having the immunological specificity thereof. Also disclosed is a device for removing cancer cells from the body of a subject.
REFERENCES:
patent: 4840915 (1989-06-01), Bogoch
patent: 4877611 (1989-10-01), Cantrell
patent: 4976957 (1990-12-01), Bogoch
patent: 5156841 (1992-10-01), Rapp
patent: 5866690 (1999-02-01), Bogoch
patent: 2007/0160624 (2007-07-01), Bogoch et al.
patent: 0015755 (1980-09-01), None
Williams et al, Methods in Immunology and Immunochemistry, Academic Press, 1967, pp. 211-215.
Ezzell, The Journal of NIH Research, 7, 46-49, 1995.
Spitler, Cancer Biotherapy, 10, 1-3, 1995.
Bogoch et al. (Neurochem. Res. 1979; 4 (4); 465-472).
Bogoch S. (1976). Brain Glycoproteins and Recognition Functions: Recognins and Cancer. In Volk BW and Schneck L (eds): “Current Trends in Sphingolipidoses and Applied Disorders”. New York: Plenum Press, pp. 555-566.
Jean-Claude Bystryn:Tumor Vaccines; Cancer and Mestastasis Review 9:81-91, 1990.
Freda K. Stevenson: Update on Tumor Vaccines; Int. J. Clin Lab Res 22:84 89, 1992.
Bogoch et al.: Tumor Markers: Malignin and Related Recognins Associated with Malignancy Rather Than With Cell Type; Neurochemistry and Clinical Neurology, pp. 407-424, Alan R. Liss, Inc. 1980.
Freda K. Stevenson:Tumor Vaccines, The FASEB Journal, vol. 5, Jun. 1991, pp. 2250-2257.
Jerrold H. Zar:Biostatistical Analysis, Prentice-Hall, Inc., Englewood Cliffs, NJ, second edition, 1984, p. 278.
Bogoch et al.:Elevated Levels of Anti-Malignin Antibody Are Quantitatively Related to Longer Survival in Cancer Patients; Prognosis, pp. 739-747, 1984.
H. Masui et al., entitled, “Cytotoxicity against Human Tumor Cells Mediated by the Conjugate of Anti-Epidermal Growth Factor Receptor Monoclonal Antibody to Recombinant Ricin A Chain”, Cancer Research, vol. 49, Jul. 1, 1989, pp. 3482-3488.
Kenyon & Kenyon LLP
Rawlings Stephen L
LandOfFree
Methods and compositions for stimulating the immune system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for stimulating the immune system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for stimulating the immune system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207636